Skip to main content

Capula Management Ltd

Position in MRNA — Moderna, Inc.

CIK 1557017 Grand Cayman, E9

Position in MRNA

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$736,600
+$501,258 QoQ
Shares Held
14,500
+70.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MRNA Over Time

Shares Held

Position Value (USD)

Derivatives in MRNA

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$2,540,000
PutShares
50,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Capula Management Ltd holds $59,978,370 across 6 Biotechnology names. MRNA ranks #5 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 MRNA
Moderna, Inc.
This page
14,500 $736,600

All Filings in MRNA

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $736,600 14,500
2026-03-31 $2,540,000 50,000
2025-06-30 $235,342 8,530
2025-06-30 $66,216 2,400
2024-12-31 $245,904 5,914
2024-06-30 $166,250 1,400
2024-06-30 $97,018 817
2024-03-31 $687,098 6,448
2024-03-31 $372,960 3,500
2023-09-30 $588,753 5,700
2023-06-30 $2,660,850 21,900
2023-06-30 $649,660 5,347
2023-06-30 $2,308,500 19,000
2023-03-31 $8,554,406 55,700
2023-03-31 $47,609 310
2023-03-31 $8,446,900 55,000
2022-09-30 $961,727 8,133
2022-09-30 $1,738,275 14,700
2021-09-30 $43,104 112
2021-09-30 $1,385,496 3,600
2021-06-30 $143,807 612
2021-06-30 $845,928 3,600